BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 17649814)

  • 1. Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus.
    Chinen K; Kamiyama K; Kinjo T; Arasaki A; Ihama Y; Hamada T; Iwamasa T
    J Clin Pathol; 2004 Sep; 57(9):918-26. PubMed ID: 15333650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.
    Mylonas I; Brüning A; Shabani N; Kunze S; Kupka MS
    Reprod Biol Endocrinol; 2010 Nov; 8():143. PubMed ID: 21092084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hormone receptors in oropharyngeal squamous cell carcinoma.
    Mohamed H; Aro K; Jouhi L; Mäkitie A; Remes S; Haglund C; Atula T; Hagström J
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1289-1300. PubMed ID: 29582173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untangling the most probable role for vitamin D
    Godar DE; Merrill SJ
    Dermatoendocrinol; 2017; 9(1):e1387702. PubMed ID: 29484101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only.
    Hertlein L; Rath J; Zeder-Göss C; Fürst S; Bayer D; Trillsch F; Mahner S; Burges A; Jeschke U
    Oncol Lett; 2017 Sep; 14(3):3302-3308. PubMed ID: 28927080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.
    Mylonas I; Makovitzky J; Friese K; Jeschke U
    Acta Histochem; 2009; 111(4):349-59. PubMed ID: 19195687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
    Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
    Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
    Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta A versus beta B: is it merely a matter of expression?
    Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.